Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Arimoclomol

EU orphan designation number: EU/3/06/406   
Active ingredient: Arimoclomol
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Orphazyme ApS
c/o COBIS A/S, Ole Maaløes Vej 3, 2200 København N, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/10/2006 Orphan designation EMEA/OD/053/06 (2006)5217 of 26/10/2006
13/01/2012 Transfer of orphan designation EMEA/OD/053/06/T/01 (2012)135 of 11/01/2012